Natixis Amgen Inc Transaction History

Natixis

$17.6 Billion
Q3 2024

A detailed history of Natixis transactions in Amgen Inc stock. As of the latest transaction made, Natixis holds 70,732 shares of AMGN stock, worth $18.6 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

70,732

Previous 7,080 899.04%

Holding current value

$18.6 Million

Previous $2.21 Million 930.29%

% of portfolio

0.13%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $19.7 Million - $21.5 Million	63,652 Added 899.04%	70,732 $22.8 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $16.8 Million - $20.4 Million	-63,980 Reduced 90.04%	7,080 $2.21 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $52.7 Million - $63.6 Million	-195,935 Reduced 73.39%	71,060 $20.2 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $28.1 Million - $31.7 Million	109,869 Added 69.92%	266,995 $76.9 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $7.5 Million - $9.31 Million	34,303 Added 27.93%	157,126 $42.2 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $44.3 Million - $52.4 Million	-206,932 Reduced 62.75%	122,823 $27.3 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $41.9 Million - $51.1 Million	-185,754 Reduced 36.03%	329,755 $79.7 Million
Q4 2022 Feb 24, 2023	BUY	$229.03 - $291.01 $17.2 Million - $21.8 Million	74,990 Added 17.02%	515,509 $135 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $77.3 Million - $98.2 Million	337,415 Added 327.26%	440,519 $116 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $5.75 Million - $6.48 Million	25,599 Added 33.03%	103,104 $23.3 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $63.7 Million - $70.8 Million	-275,958 Reduced 78.07%	77,505 $18.9 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $26.7 Million - $29.6 Million	121,856 Added 52.61%	353,463 $85.5 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $34 Million - $38.9 Million	170,978 Added 282.01%	231,607 $52.1 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $21.2 Million - $24.8 Million	-99,802 Reduced 62.21%	60,629 $12.9 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $3.43 Million - $3.81 Million	14,705 Added 10.09%	160,431 $39.1 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $7.22 Million - $8.41 Million	-32,535 Reduced 18.25%	145,726 $36.3 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $38.6 Million - $45.9 Million	178,261 New	178,261 $41 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $37.9 Million - $42.1 Million	-161,524 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $61.6 Million - $75.6 Million	-311,517 Reduced 65.85%	161,524 $38.1 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $34.8 Million - $46.2 Million	-191,224 Reduced 28.79%	473,041 $95.9 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $98.9 Million - $127 Million	-522,634 Reduced 44.03%	664,265 $160 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $207 Million - $248 Million	1,186,899 New	1,186,899 $230 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $69.8 Million - $81.8 Million	-418,718 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $75.7 Million - $85.4 Million	418,718 New	418,718 $78.6 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $98.2 Million - $111 Million	-529,816 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $84.7 Million - $95.2 Million	510,281 Added 2612.14%	529,816 $97.8 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $15.5 Million - $18.1 Million	-91,245 Reduced 82.37%	19,535 $3.33 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $2.16 Million - $2.41 Million	-12,778 Reduced 10.34%	110,780 $19.3 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $20.7 Million - $23.6 Million	123,558	123,558 $23 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account